WHAT TO EXPECT FROM A PHENYTOIN DRUG-DRUG INTERACTION STUDY: ADVERSE EVENT PROFILING AND SAFETY ASSESSMENT

被引:0
|
作者
Paglialunga, S. [1 ]
van Haarst, A. [2 ]
机构
[1] Celerion, Tempe, AZ USA
[2] Celerion, Belfast, Antrim, North Ireland
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PII-032
引用
收藏
页码:S57 / S57
页数:1
相关论文
共 50 条
  • [21] What can anesthesiology learn from the adverse drug event prevention study?
    Pierce, EC
    JOURNAL OF CLINICAL ANESTHESIA, 2000, 12 (08) : 579 - 580
  • [22] Use of an algorithm for identifying hidden drug-drug interactions in adverse event reports
    Gooden, Kyna McCullough
    Pan, Xianying
    Kawabata, Hugh
    Heim, Jean-Marie
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2013, 20 (03) : 590 - 590
  • [23] Drug-drug interaction from the standpoint of pharmacokineties
    Ohdo, S
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 28P - 28P
  • [24] Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports
    Cai, Ruichu
    Liu, Mei
    Hu, Yong
    Melton, Brittany L.
    Matheny, Michael E.
    Xu, Hua
    Duan, Lian
    Waitman, Lemuel R.
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2017, 76 : 7 - 15
  • [25] Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 309 - 309
  • [26] Adverse events targeted by drug-drug interaction alerts in hospitalized patients
    Gatenby, James
    Blomqvist, Magnus
    Burke, Rosemary
    Ritchie, Angus
    Gibson, Kathy
    Patanwala, Asad E.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2020, 143 (143)
  • [27] Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
    Morganne Sindelar
    Daniel McCabe
    Elisabeth Carroll
    Journal of Medical Toxicology, 2023, 19 : 309 - 309
  • [28] Drug-drug interaction in reverse: Possible loss of phenytoin efficacy as a result of fluoxetine discontinuation
    Shad, MU
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 471 - 472
  • [29] Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort
    Candeloro, Matteo
    Eikelboom, John W.
    Chan, Noel
    Bhagirath, Vinai
    Douketis, James D.
    Schulman, Sam
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
  • [30] Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database
    Leone, R.
    Moretti, U.
    Conforti, A.
    Magro, L.
    Moschini, M.
    Tuccori, M.
    Cutroneo, P.
    Motola, D.
    Velo, G. P.
    DRUG SAFETY, 2008, 31 (10) : 938 - 938